Lisa R. Gerak

1.4k total citations
87 papers, 1.1k citations indexed

About

Lisa R. Gerak is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Lisa R. Gerak has authored 87 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Cellular and Molecular Neuroscience, 25 papers in Molecular Biology and 20 papers in Cognitive Neuroscience. Recurrent topics in Lisa R. Gerak's work include Neurotransmitter Receptor Influence on Behavior (42 papers), Neuroscience and Neuropharmacology Research (33 papers) and Memory and Neural Mechanisms (17 papers). Lisa R. Gerak is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (42 papers), Neuroscience and Neuropharmacology Research (33 papers) and Memory and Neural Mechanisms (17 papers). Lisa R. Gerak collaborates with scholars based in United States and United Kingdom. Lisa R. Gerak's co-authors include Charles P. France, David R. Maguire, Gregory T. Collins, Lance Richard McMahon, Peter J. Winsauer, Ginger L. Becker, James H. Woods, Joseph M. Moerschbaecher, James H. Woods and Martin A. Javors and has published in prestigious journals such as The FASEB Journal, Journal of Pharmacology and Experimental Therapeutics and Neuropsychopharmacology.

In The Last Decade

Lisa R. Gerak

87 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa R. Gerak United States 20 832 296 245 200 172 87 1.1k
S E Lukas United States 18 628 0.8× 276 0.9× 172 0.7× 100 0.5× 156 0.9× 31 1.0k
S. Stevens Negus United States 23 1.1k 1.3× 437 1.5× 242 1.0× 346 1.7× 202 1.2× 52 1.4k
Vanessa Mitchell Australia 22 597 0.7× 255 0.9× 700 2.9× 467 2.3× 151 0.9× 40 1.3k
Megan J. Shram Canada 16 539 0.6× 458 1.5× 95 0.4× 214 1.1× 112 0.7× 32 949
Marvin C. Wilson United States 21 795 1.0× 388 1.3× 143 0.6× 167 0.8× 126 0.7× 63 1.4k
Jewell W. Sloan United States 17 942 1.1× 400 1.4× 325 1.3× 313 1.6× 266 1.5× 55 1.7k
Matthew Randesi United States 20 570 0.7× 391 1.3× 204 0.8× 225 1.1× 128 0.7× 48 1.2k
Jillian H. Broadbear Australia 22 526 0.6× 305 1.0× 197 0.8× 185 0.9× 123 0.7× 86 1.4k
Nicole L. Schramm‐Sapyta United States 17 674 0.8× 264 0.9× 190 0.8× 101 0.5× 204 1.2× 26 1.1k
Bruno Ribeiro Do Couto Spain 16 542 0.7× 198 0.7× 157 0.6× 111 0.6× 242 1.4× 29 1.0k

Countries citing papers authored by Lisa R. Gerak

Since Specialization
Citations

This map shows the geographic impact of Lisa R. Gerak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa R. Gerak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa R. Gerak more than expected).

Fields of papers citing papers by Lisa R. Gerak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa R. Gerak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa R. Gerak. The network helps show where Lisa R. Gerak may publish in the future.

Co-authorship network of co-authors of Lisa R. Gerak

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa R. Gerak. A scholar is included among the top collaborators of Lisa R. Gerak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa R. Gerak. Lisa R. Gerak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Snyder, Gretchen L., Peng Li, Lei Zhang, et al.. (2024). Pharmacologic profile of ITI-333: a novel molecule for treatment of substance use disorders. Psychopharmacology. 241(7). 1477–1490. 1 indexed citations
2.
Gray, Richard A., David J. Heal, David R. Maguire, et al.. (2022). Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical Dependence. Journal of Pharmacology and Experimental Therapeutics. 382(1). 54–65. 8 indexed citations
3.
Maguire, David R., Lisa R. Gerak, Martin A. Javors, et al.. (2020). Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys. Neuropsychopharmacology. 45(12). 1986–1993. 15 indexed citations
4.
Jiménez, Víctor, David R. Maguire, Lisa R. Gerak, & Charles P. France. (2020). Methocinnamox (MCAM) Reverses and Provides Extended Protection from Fentanyl‐Induced Respiratory Depression in Awake Unrestrained Rats. The FASEB Journal. 34(S1). 1–1. 1 indexed citations
5.
Gerak, Lisa R., et al.. (2019). Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats. Journal of Pharmacology and Experimental Therapeutics. 371(2). 507–516. 17 indexed citations
6.
Gerak, Lisa R., David R. Maguire, & Charles P. France. (2019). Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors. Handbook of experimental pharmacology. 258. 127–145. 6 indexed citations
7.
Gerak, Lisa R., Gregory T. Collins, David R. Maguire, & Charles P. France. (2018). Effects of lorcaserin on reinstatement of responding previously maintained by cocaine or remifentanil in rhesus monkeys.. Experimental and Clinical Psychopharmacology. 27(1). 78–86. 23 indexed citations
8.
Gerak, Lisa R., David R. Maguire, James H. Woods, et al.. (2018). Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel μ-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 368(2). 229–236. 23 indexed citations
9.
Maguire, David R., Lisa R. Gerak, James H. Woods, et al.. (2018). Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 368(1). 88–99. 25 indexed citations
10.
France, Charles P., et al.. (2017). Preference for an Opioid/Benzodiazepine Mixture over an Opioid Alone Using a Concurrent Choice Procedure in Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 362(1). 59–66. 10 indexed citations
11.
Zanettini, Claudio, et al.. (2016). Comparing the discriminative stimulus effects of modulators of GABAA receptors containing α4-δ subunits with those of gaboxadol in rats. Psychopharmacology. 233(10). 2005–2013. 5 indexed citations
12.
Gerak, Lisa R., Claudio Zanettini, Wouter Koek, & Charles P. France. (2015). Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys. Psychopharmacology. 232(19). 3637–3647. 21 indexed citations
13.
Becker, Ginger L., Lisa R. Gerak, Jun‐Xu Li, Wouter Koek, & Charles P. France. (2010). Precipitated and conditioned withdrawal in morphine-treated rats. Psychopharmacology. 209(1). 85–94. 12 indexed citations
14.
Li, Jun‐Xu, Lance Richard McMahon, Lisa R. Gerak, Ginger L. Becker, & Charles P. France. (2008). Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception. Psychopharmacology. 199(2). 199–208. 52 indexed citations
15.
Becker, Ginger L., Lisa R. Gerak, Wouter Koek, & Charles P. France. (2008). Antagonist-precipitated and discontinuation-induced withdrawal in morphine-dependent rhesus monkeys. Psychopharmacology. 201(3). 373–382. 18 indexed citations
16.
McMahon, Lance Richard, Lisa R. Gerak, & Charles P. France. (2006). Efficacy and the Discriminative Stimulus Effects of Negative GABAA Modulators, or Inverse Agonists, in Diazepam-Treated Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 318(2). 907–913. 3 indexed citations
17.
McMahon, Lance Richard, Lisa R. Gerak, Lawrence Carter, et al.. (2002). Discriminative Stimulus Effects of Benzodiazepine (BZ)1 Receptor-Selective Ligands in Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 300(2). 505–512. 12 indexed citations
18.
Gerak, Lisa R., William L. Woolverton, Michael A. Nader, et al.. (2001). Behavioral effects of flunitrazepam: reinforcing and discriminative stimulus effects in rhesus monkeys and prevention of withdrawal signs in pentobarbital-dependent rats. Drug and Alcohol Dependence. 63(1). 39–49. 7 indexed citations
19.
Woolverton, William L., James K. Rowlett, Gail Winger, et al.. (1999). Evaluation of the reinforcing and discriminative stimulus effects of γ-hydroxybutyrate in rhesus monkeys. Drug and Alcohol Dependence. 54(2). 137–143. 35 indexed citations
20.
Gerak, Lisa R., et al.. (1998). EFFECTS OF A NOVEL FENTANYL DERIVATIVE ON DRUG DISCRIMINATION AND LEARNING IN RHESUS MONKEYS. Behavioural Pharmacology. 9(1). S109–S109. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026